Cargando…
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
SIMPLE SUMMARY: Treating biliary tract cancer (BTC) successfully remains to be a difficult task. Standard therapeutic options encompass surgery, radiation and chemotherapy, but the median survival has not improved beyond one year. The reasons for this might be diagnosis at an already late stage and...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000745/ https://www.ncbi.nlm.nih.gov/pubmed/36900361 http://dx.doi.org/10.3390/cancers15051569 |